Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6748 stock hub

TPEX/6748 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6748is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.3B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6748
In the news

Latest news · TPEX/6748

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-9.6
P25 -16.2P50 0.3P75 9.8
ROIC-6.6
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6748 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
169
Groups with data
11
Currency
TWD
Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Taiwan
Country code
TW
Enterprise value
TWD 3.4B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0006748007
Last refreshed
2026-05-10
Market cap
TWD 4.3B
Price
TWD 71.2
Price currency
TWD
Sector
Healthcare
Sic
2836
Symbol
tpex/6748
Website
https://www.acrobiomedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-1.9%
EV Earnings
-40.88x
EV/FCF
-54.66x
EV/Sales
88.33x
FCF yield
-1.42%
P/B ratio
3.94x
P/S ratio
113.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-241.06%
EBITDA Margin
-211.57%
Gross margin
48.43%
Gross Profit
TWD 18.5M
Gross Profit Growth
5.6%
Gross Profit Growth Q
-69.87%
Gross Profit Growth3 Y
-23.68%
Gross Profit Growth5 Y
2.71%
Net Income
TWD -82.7M
Net Income Growth Years
0%
Pretax Margin
-216.06%
Profit Margin
-216.06%
ROA
-6.45
Roa5y
-10.19
ROCE
-8.29
ROE
-9.55
Roe5y
-16.73
ROIC
-6.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
83.88%
Cagr3y
38.36%
EPS Growth Years
0
Revenue Growth
-13.51x
Revenue Growth Q
-36.73x
Revenue Growth Quarters
1x
Revenue Growth Years
0x
Revenue Growth3 Y
-12.09x
Revenue Growth5 Y
4.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
TWD 0.04
Assets
TWD 1.1B
Cash
TWD 977.9M
Current Assets
TWD 481.4M
Current Liabilities
TWD 16.7M
Debt
TWD 10.6M
Debt Equity
TWD 0.01
Debt FCF
TWD -0.17
Equity
TWD 1.1B
Interest Coverage
-411.7
Liabilities
TWD 28.1M
Long Term Assets
TWD 651.2M
Long Term Liabilities
TWD 11.4M
Net Cash
TWD 967.3M
Net Cash By Market Cap
TWD 22.25
Net Cash Growth
-14.29%
Net Debt Equity
TWD -0.88
Tangible Book Value
TWD 1.1B
Tangible Book Value Per Share
TWD 17.92
WACC
6.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
51.12
Inventory Turnover
1.69
Net Working Capital
TWD 10.5M
Quick ratio
49.9
Working Capital
TWD 986.2M
Working Capital Turnover
TWD 0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
83.8%
200-day SMA
67.28
3Y total return
164.94%
50-day SMA
65.72
50-day SMA vs 200-day SMA
50under200
All Time High
94.3
All Time High Change
-24.5%
All Time High Date
2025-08-04
All Time Low
16.7
All Time Low Change
326.35%
All Time Low Date
2022-07-15
ATR
3.9
Beta
0.41
Beta1y
-0.68
Beta2y
-0.37
Ch YTD
7.88
High
72.8
High52
94.3
High52 Date
2025-08-05
High52ch
-24.5%
Low
69.3
Low52
33.85
Low52 Date
2025-07-01
Low52ch
110.34%
Ma50ch
8.33%
Price vs 200-day SMA
5.83%
RSI
55.19
RSI Monthly
65.5
RSI Weekly
59.1
Sharpe ratio
1.25x
Sortino ratio
2.58
Total Return
0.4%
Tr YTD
7.88
Tr1m
5.33%
Tr1w
-1.52%
Tr3m
2.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -92.2M
Operating margin
-241.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
43,217,524%
Net Borrowing
-5,256,000
Shares Insiders
16.63%
Shares Out
61,218,198
Shares Qo Q
0%
Shares Yo Y
-0.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Adjusted FCF
TWD -64.5M
Average Volume
438,234.8x
Bv Per Share
18.04
CAPEX
TWD -12.8M
Ch1m
5.33
Ch1w
-1.52
Ch1y
81.87
Ch3m
2.59
Ch3y
160.8
Ch6m
11.25
Change
0.56%
Change From Open
-0.42
Close
70.8
Days Gap
0.99
Depreciation Amortization
11,280,000
Dollar Volume
19,306,378.4
Earnings Date
2026-05-14
EBIT
TWD -92.2M
EBITDA
TWD -80.9M
EPS
TWD -1.35
F Score
3
FCF
TWD -61.8M
FCF EV Yield
-1.83x
FCF Per Share
TWD -1.01
Financing CF
544,759,000
Fiscal Year End
December
Founded
2,014
Investing CF
84,405,000
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-06-30
Ma150
65.74
Ma150ch
8.3%
Ma20
69.65
Ma20ch
2.23%
Net CF
578,926,000
Next Earnings Date
2026-05-14
Open
71.5
Position In Range
54.29
Ppne
58,588,000
Price Date
2026-05-08
Ptbv Ratio
3.96
Relative Volume
0.62x
Revenue
38,255,000x
SBC By Revenue
6.88x
Share Based Comp
2,632,000
Tr6m
12.44%
Volume
271,157
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/6748 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6748 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+83.8%
S&P 500 1Y: n/a
3Y total return
+164.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6748?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+16.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.4%
Negative means the company is buying back shares.
Technical

TPEX/6748 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.2
Neutral momentum band
Price vs 200-day MA
+5.8%
50/200-day relationship not available
Beta (5Y)
0.41
Less volatile than the market
Sharpe ratio
1.25
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6748

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6748 stock rating?

tpex/6748 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6748 analysis?

The full report lives at /stocks/tpex/6748/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6748?

The latest report frames tpex/6748 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6748 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.